UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.175

Sortiert nach

Prognostic Value of Cardiac Computed Tomography Angiography: A Systematic Review and Meta-Analysis

Journal of the American College of Cardiology, 2011-03, Vol.57 (10), p.1237-1247

2011

Link zum Volltext

Verfügbarkeit prüfen

Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK‐21273 in comparison with SB‐612111

British journal of pharmacology, 2013-02, Vol.168 (4), p.863-879

2013

Link zum Volltext

Verfügbarkeit prüfen

Time-series of peripheral blood biomarkers as biomarkers for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Annals of oncology, 2019-04, Vol.30, p.ii34-ii34

2019

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood biomarkers as prognostic factors for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Annals of oncology, 2019-04, Vol.30, p.ii58-ii58

2019

Link zum Volltext

Verfügbarkeit prüfen

Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)

The Journal of pharmacology and experimental therapeutics, 2004-02, Vol.308 (2), p.454

2004

Link zum Volltext

Verfügbarkeit prüfen

Early onset transient liver disease and rare allelic variants alpha-1 antitrypsin deficiency (A1ATD) Plowell and Mheerlen

Digestive and liver disease, 2016-10, Vol.48, p.e254-e254

2016

Link zum Volltext

Verfügbarkeit prüfen

Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist

The Journal of pharmacology and experimental therapeutics, 2010-12, Vol.335 (3), p.622

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Cardiac Computed Tomography Angiography

Journal of the American College of Cardiology, 2011-03, Vol.57 (10), p.1237-1247

2011

Link zum Volltext

Verfügbarkeit prüfen

P2.10-05 Circulating CD3+CD56+ Cells as a Biomarker for Immunotherapy in SCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S147-S148

2022

Link zum Volltext

Verfügbarkeit prüfen

P75.14 Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S579-S580

2021

Link zum Volltext

Verfügbarkeit prüfen

EP01.01-12 Binge-Watching Frequency and Tobacco Use in Adolescents: Data from “Blaam Smoke-Free Movie” Program

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S418

2023

Link zum Volltext

Verfügbarkeit prüfen

P2.10-06 Smoking Prevalence and Perceptions Among Healthcare Professionals: A Survey in an Italian Clinical Cancer Centre

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S786-S787

2019

Link zum Volltext

Verfügbarkeit prüfen

Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists

Medicinal research reviews, 2009-11, Vol.29 (6), p.867-902

2009

Link zum Volltext

Verfügbarkeit prüfen

Predictive score using clinical and blood biomarkers in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

Annals of oncology, 2018-12, Vol.29, p.x2-x2

2018

Link zum Volltext

Verfügbarkeit prüfen

P3.04-12 Prognostic and Predictive Role of Peripheral Blood Biomarkers in NSCLC Patients Treated with Checkpoint, a Single-Center Experience

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S926-S926

2018

Link zum Volltext

Verfügbarkeit prüfen

Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists

Journal of medicinal chemistry, 2001-05, Vol.44 (11), p.1675-1689

2001

Link zum Volltext

Verfügbarkeit prüfen

MA10.05 Breath Analysis: New Key-Challenges for Early Detection of Lung and Pleural Neoplasms

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S287-S287

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-peptide δ opioid agonists and antagonists (Part II)

Expert opinion on therapeutic patents, 1999-04, Vol.9 (4), p.353-374

1999

Link zum Volltext

Verfügbarkeit prüfen

Non-peptide δ opioid agonists and antagonists

Expert opinion on therapeutic patents, 1997-10, Vol.7 (10), p.1075-1098

1997

Link zum Volltext

Verfügbarkeit prüfen

P3.06-003 What Do the Children Think about Smoking and How Are They Helped in Prevention?

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2295-S2295

2017

Link zum Volltext

Verfügbarkeit prüfen

Sequential Combination of Low Dose Chemo-Modulating Temozolomide with Fotemustine in Metastatic Melanoma (MM). A Phase II Study

Annals of oncology, 2012-09, Vol.23, p.ix370

2012

Link zum Volltext

Verfügbarkeit prüfen

1135P - Sequential Combination of Low Dose Chemo-Modulating Temozolomide with Fotemustine in Metastatic Melanoma (MM). A Phase II Study

Annals of oncology, 2012-09, Vol.23, p.ix370-ix370

2012

Link zum Volltext

Verfügbarkeit prüfen

Evidence for a selective role of the delta-opioid agonist [8R-(4bS,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses

The Journal of pharmacology and experimental therapeutics, 2003-12, Vol.307 (3), p.1079

2003

Link zum Volltext

Verfügbarkeit prüfen

Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats

The Journal of pharmacology and experimental therapeutics, 1990-07, Vol.254 (1), p.91

1990

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of the American College of Cardiology, 2011-06, Vol.57 (25), p.2544

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(858)
Mit Volltextzugriff
(1.072)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(430)
Physics
(280)
Physical Sciences
(223)
Life Sciences & Biomedicine
(185)
Humans
(162)
Physics Of Elementary Particles And Fields
(146)
Physics, Particles & Fields
(106)
Female
(97)
Male
(97)
Biological And Medical Sciences
(83)
Technology
(73)
High Energy Physics - Experiment
(70)
Medical Sciences
(68)
Astronomy & Astrophysics
(63)
Fysik
(63)
Exact Sciences And Technology
(59)
Natural Sciences
(59)
Naturvetenskap
(59)
Middle Aged
(55)
Physics, Nuclear
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Prognostic Value of Cardiac Computed Tomography Angiography: A Systematic Review and Meta-Analysis

Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK‐21273 in comparison with SB‐612111

Time-series of peripheral blood biomarkers as biomarkers for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Peripheral blood biomarkers as prognostic factors for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)

Early onset transient liver disease and rare allelic variants alpha-1 antitrypsin deficiency (A1ATD) Plowell and Mheerlen

Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist

Prognostic Value of Cardiac Computed Tomography Angiography

P2.10-05 Circulating CD3+CD56+ Cells as a Biomarker for Immunotherapy in SCLC

P75.14 Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

EP01.01-12 Binge-Watching Frequency and Tobacco Use in Adolescents: Data from “Blaam Smoke-Free Movie” Program

P2.10-06 Smoking Prevalence and Perceptions Among Healthcare Professionals: A Survey in an Italian Clinical Cancer Centre

Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists

Predictive score using clinical and blood biomarkers in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

P3.04-12 Prognostic and Predictive Role of Peripheral Blood Biomarkers in NSCLC Patients Treated with Checkpoint, a Single-Center Experience

Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists

MA10.05 Breath Analysis: New Key-Challenges for Early Detection of Lung and Pleural Neoplasms

Non-peptide δ opioid agonists and antagonists (Part II)

Non-peptide δ opioid agonists and antagonists

P3.06-003 What Do the Children Think about Smoking and How Are They Helped in Prevention?

Sequential Combination of Low Dose Chemo-Modulating Temozolomide with Fotemustine in Metastatic Melanoma (MM). A Phase II Study

1135P - Sequential Combination of Low Dose Chemo-Modulating Temozolomide with Fotemustine in Metastatic Melanoma (MM). A Phase II Study

Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats

Reply

Suchergebnisse filtern